TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
XOMA

XOMA Royalty Corporation

Healthcare · Biotechnology

40.20$ +0.0% vs. previous close Closing price · As of: Jul 21, 2026

Statements

Balance Sheet

XOMA Royalty Corporation (XOMA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 272 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet XOMA
Line item Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
39 25 29 23 24 50 45 43 41 46 64 76 78 86 96 92 88 86 125 120 136 131 167 159 154 146 140 134 126 124 234 219 243 223 221 213 223 263 273 272
36 23 27 22 23 49 44 43 40 30 48 51 46 44 60 56 52 48 88 70 87 75 97 90 87 80 61 45 38 35 169 147 162 159 126 113 105 111 117 119
34 21 26 20 12 48 43 42 39 28 46 48 42 40 57 53 49 46 84 68 79 69 93 88 83 78 58 44 31 33 153 136 144 142 102 90 75 90 83 94
34 21 26 20 12 48 43 42 39 28 46 48 42 40 57 53 49 46 84 68 81 70 94 88 84 79 58 45 32 34 153 137 145 143 105 93 84 92 83 95
1.0 0.8 0.6 1.3 11 1.0 0.4 0.4 0.5 1.3 1.5 2.8 2.6 3.8 2.9 2.8 1.9 1.7 1.8 0.1 0.0 0.5 0.2 0.0 2.5 0.0 2.4 0.0 5.9 0.0 15 9.8 15 14 17 18 20 18 4.9 23
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – 0.0 0.0 0.0 – 0.0 1.6 2.1 4.8 3.4 2.0 0.0 0.0 -0.4 0.0 – – – 0.0 0.0 – -2.4 – – – – – –
1.6 1.4 1.0 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – 15 15 15 14 – – – – 26 25 45 45 45 44
59 56 76 54 53 46 39 38 36 45 45 52 57 60 52 51 49 48 39 38 19 19 25 19 19 16 16 19 16 18 146 137 143 139 139 128 131 155 169 159
24 23 33 22 22 14 7.4 5.9 3.2 5.6 5.7 7.1 12 10 8.9 10 11 12 12 13 6.3 6.5 13 7.9 8.4 5.4 6.8 10 7.1 10 19 16 19 21 24 20 21 28 35 33
12 12 18 13 14 3.8 3.4 2.8 1.0 1.9 0.8 6.2 7.3 8.7 5.3 6.7 7.9 9.3 8.3 7.6 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.0 3.5 5.6 6.2 6.1 10 12 14 12 17 15 16
5.0 4.5 5.7 4.2 3.5 4.0 1.7 1.4 1.1 1.5 1.2 1.0 1.4 0.9 0.6 0.7 0.6 0.5 0.5 0.7 0.6 0.6 1.1 0.8 1.2 1.0 0.5 0.4 0.7 0.7 0.7 1.5 1.0 1.1 1.1 2.3 1.1 2.7 2.2 3.5
34 33 25 14 14 14 15 15 15 22 22 21 23 29 27 25 23 21 13 12 – – – – – – – – – – 119 115 115 108 107 100 102 94 96 89
-20 -31 -47 -31 -29 4.1 5.8 5.6 4.9 1.2 19 24 21 26 44 41 38 38 86 82 117 112 142 140 135 130 124 115 110 106 89 82 100 85 82 85 92 108 104 113
-1,164 -1,176 -1,194 -1,204 -1,204 -1,178 -1,179 -1,183 -1,185 -1,189 -1,192 -1,189 -1,193 -1,190 -1,194 -1,199 -1,203 -1,204 -1,181 -1,188 -1,191 -1,195 -1,165 -1,168 -1,172 -1,176 -1,182 -1,192 -1,198 -1,203 -1,223 -1,232 -1,216 -1,233 -1,237 -1,235 -1,228 -1,214 -1,221 -1,217
6.0 6.0 6.1 6.9 7.6 8.3 8.2 8.3 8.4 8.4 8.4 9.3 8.7 9.4 8.9 9.8 11 11 12 11 11 11 12 11 11 11 11 11 11 11 11 12 12 12 12 15 18 18 18 17

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?